This is an aggregated industry headline. Read the full story at FierceBiotech →
ARPA-H awards up to $160M to scientists developing custom genetic medicines
The Advanced Research Projects Agency for Health has awarded a new tranche of funds for companies and institutions developing personalized genetic medicines, with the recipient list dominated by high-profile players in the buzzy field.
By FierceBiotech
· Jul 10, 2026
· via FierceBiotech
RxInsider combines reported facts with industry analysis and informed inference. Forward-looking reads, market commentary, and interpretive framing reflect analysis of available reporting and known facts, not confirmed outcomes.
Tags
theweekformat:headlineheadlineFierceBiotech
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
Bleeding disorder patient groups put Sobi, Roche and Novo Nordisk on the podium in 2025/2026's corporate reput…
The WeekBriefing
The August 5 meeting will explore how to identify and prioritize FDA-approved drugs for new indications and po…
The WeekPharmaceutical Technology ↗
Apertura has entered a CRADA with various NIH institutes for a gene therapy to treat Niemann-Pick Disease Type…